Evidence map›Paper›PMID 40817074›Full record

ReviewCell death discovery2025

Dual role mechanisms of regulated cell death in apical periodontitis: from pathogenic destruction to therapeutic potential.

Yu Cao, Shipeng Yang, Quzhen Baima, Yuqi Zhen, Xinyue Hang, Xiuping Meng

Abstract readReview
In one paragraph

Review in Cell death discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yu CaoDepartment of Endodontics, Hospital of Stomatology, Jilin University, Changchun, Jilin, PR China.
Shipeng YangDepartment of Endodontics, Hospital of Stomatology, Jilin University, Changchun, Jilin, PR China.
Quzhen BaimaDepartment of Endodontics, Hospital of Stomatology, Jilin University, Changchun, Jilin, PR China.
Yuqi ZhenDepartment of Endodontics, Hospital of Stomatology, Jilin University, Changchun, Jilin, PR China.
Xinyue HangDepartment of Oral, Plastic and Aesthetic Surgery, Hospital of Stomatology, Jilin University, Changchun, Jilin, PR China.
Xiuping MengDepartment of Endodontics, Hospital of Stomatology, Jilin University, Changchun, Jilin, PR China. mengxp@jlu.edu.cn.ORCID http://orcid.org/0000-0002-9891-004X

Funding

Department of Science and Technology of Jilin Province (Jilin Province Science and Technology Department) jcsz2023481-18
6 · The paper itself

Abstract

Apical periodontitis (AP), a highly prevalent infectious disease driven by pathogenic microorganisms residing in periapical tissues, orchestrates a dynamic interplay between microbial virulence and host immune defenses. Emerging evidence indicates that these pathogens critically manipulate regulated cell death (RCD) pathways to subvert immune surveillance and dictate periapical bone remodeling outcomes. While RCD has traditionally been viewed as a dichotomy between pro-inflammatory destruction and anti-inflammatory repair, recent advances reveal its context-dependent duality, shaped by microbial-immune crosstalk. Despite growing interest in this field, current literature lacks a comprehensive synthesis delineating the dual-pathological impact of RCD mechanisms in AP progression, particularly their beneficial versus detrimental roles. This review critically evaluates the molecular mechanisms of RCD and crosstalk among its forms, delineating its dual roles in immune defense versus bone destruction during AP progression. We synthesize current understanding of RCD pathways in AP pathogenesis and explore therapeutically targeting these mechanisms to modulate disease outcomes. Furthermore, we explore the feasibility of developing therapeutic strategies for AP based on RCD targets and propose novel research directions to advance understanding and treatment of this condition.

Identifiers

PMID40817074
PMCPMC12356886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.